Showing 4 results for Ejtahed
Zeynab Amirhamidi, Hanieh-Sadat Ejtahed, Zahra Bahadoran, Parvin Mirmiran, Fereidoun Azizi,
Volume 14, Issue 4 (5-2015)
Abstract
Background: Existing studies show that a poor diet has an effect on the progression of non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to systematically summarize the results of studies on the relationship between dietary intakes and NAFLD. Methods: A review of Scopus, PubMed, Cochrane Library, Magiran, Medlib and SID databases and theses in the National Library of the Islamic Republic of Iran was conducted to identify epidemiological studies concerning NAFLD, food groups and dietary patterns. Cross-sectional, case-control and cohort studies with documented in English were selected for this systematic review. Duplication, topic, type of study, study population, variables examined and quality of data reporting of articles were evaluated. Results: Of 2128 articles found in the initial search, 33 were reviewed in full-text of these 6 articles were included in the systematic review. The literature review showed patients with NAFLD consumed more red meat, fats and sweets and less whole grains, fruits and vegetables. The Western dietary pattern was positively associated with the risk of NAFLD and adherence to the Mediterranean diet was negatively correlated to hepatic steatosis. Conclusion: The results of the systematic review indicate that different dietary intakes may be associated with development of NAFLD and its related factors. Due to limited research documented on this topic, further prospective studies are recommended.
Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar, Hanieh Malmir, Azin Pakmehr, Rezvan Razmande, Yasaman Khorshidi, Golaleh Asghari, Ahmadreza Soroush, Afshin Ostovar, Bagher Larijani,
Volume 23, Issue 6 (1-2024)
Abstract
Background: Considering the increasing and alarming trend of overweight and obesity as well as its related complications, in this study, a comprehensive clinical guide for the medical care of patients with obesity was written based on the clinical recommendations of the American Endocrinology Association and the American College of Endocrinology, and it has been adjusted as much as possible based on the conditions in Iran.
Methods: A complete search was performed in the available databases without any restrictions with a specific strategy. Using the opinions of experts in this field, the best clinical guidelines were selected and obesity clinical guidelines were written for Iranian adults. Recommendations were given based on a detailed review of available clinical evidence and considering objective factors.
Results: A total of 1788 references were used and in response to 9 clinical questions, 123 recommendations, including 160 special statements, were provided to determine a comprehensive medical care program for obesity. In this article, we discuss the prevention, screening, diagnosis, benefits and goals of obesity treatment. Questions 6 to 9 regarding obesity treatment steps and its individualization will be published in the next part of the article.
Conclusion: The detailed evidence-based questions and recommendations outlined in this study identify clinical considerations that facilitate decision-making in obese patients from screening and diagnosis to goals of treatment.
Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar, Hanieh Malmir, Rezvan Razmandeh, Azin Pakmehr, Yasaman Khorshidi, Golaleh Asghari, Amir Mohammad Mortazavian, Mohammad Reza Mohajer-Tehrani, Afshin Ostovar, Bagher Larijani,
Volume 24, Issue 1 (3-2024)
Abstract
Background: The prevalence of overweight, obesity and related complications is increasing rapidly in the world. Also, treating this disease in the presence or absence of co-morbidities has become a challenge. In this article, based on the clinical recommendations of the American Endocrinology Association and the American College of Endocrinology, a comprehensive clinical guide has been written for the stages of treating obese patients and its individualization, and it has been tried to be adjusted as much as possible based on the conditions in Iran.
Methods: with a specific search strategy, a complete search was performed in PubMed, Scopus, ISI Web of Science, EMBASE and Google Scholar Cochrane databases. Then, the best clinical guidelines suitable for the Iranian society were selected and using the opinions of specialists and clinical experts, a clinical guideline was prepared for the treatment of obesity in Iranian adults.
Results: In this article, in continuation of the previous article, we answered the questions number 4 to 6 regarding the stages of obesity treatment and its individualization in adults of Iranian society, and presented a total of 60 recommendations in this regard.
Conclusion: In this part of the clinical guide for obesity in Iranian adults, we tried to have a special view on the treatment of these patients and by providing evidence-based recommendations and statements, the treatment process was personalized as much as possible for patients with special conditions so that decision-making in this regard is facilitated for the relevant colleagues in this field.
Zahra Hoseini Tavassol, Mona Tamaddon, Hanieh-Sadat Ejtahed, Bagher Larijani,
Volume 25, Issue 5 (12-2025)
Abstract
Desmond et al. (2025) have recently shown that subcutaneous injections of Mycobacterium vaccae ATCC 15483(M. vaccae) in adolescent male mice significantly prevented excessive weight gain and visceral adiposity induced by a Western-style diet. Despite no change in gut microbiota diversity, this intervention lowered hippocampal neuroinflammation markers (Nfkbia, Nlrp3) and anxiety-like behaviors. Since more than one billion people worldwide and about 30% of Iranian population are influenced by obesity, and this disease caused one in eight deaths from noncommunicable diseases in 2024, these microbiome-based strategies could have clinical value. Such approaches that target immunometabolic pathways represent a promising and interdisciplinary strategy that integrates endocrinology, microbiology, and the psychosomatic aspects of metabolic disorders. Nevertheless, M. vaccae media portrayal as an obesity vaccine causes misunderstanding. This treatment reduces, but does not completely hinder, diet-associated weight gain and could not be replaced with healthy diet habits. However, it could be considered as a supplementary approach to reduce the adverse effects of ultra-processed food consumption and could potentially augment existing obesity treatments, such as microbiome-based interventions, pharmaceutical therapies, and bariatric surgery. More extensive clinical trials are required to determine human efficacy, optimal dosing, safety, and integration with current obesity therapies.
